Steven Allen to Prospective Studies
This is a "connection" page, showing publications Steven Allen has written about Prospective Studies.
Connection Strength
0.281
-
Allen SR, Slaughter MS, Ahmed MM, Bartoli CR, Dhingra R, Egnaczyk GF, Gulati SK, Kiernan MS, Mahr C, Meyer DM, Motomura T, Ono M, Ravichandran A, Shafii A, Smith J, Soleimani B, Toyoda Y, Yarboro LT, Dowling RD. COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. J Heart Lung Transplant. 2023 01; 42(1):33-39.
Score: 0.121
-
McLaughlin CJ, Hess J, Armen SB, Allen SR. Established Primary Care Provider Improves Odds of Survival to Discharge for Injured Patients. J Surg Res. 2021 11; 267:619-626.
Score: 0.111
-
Kulaylat AN, Saunders BD, Allen SR, Aarons CB, Hoffman RL. Evaluating the Implementation of a Medical Student's Handoff Curriculum During the Surgery Clerkship. J Surg Res. 2023 02; 282:262-269.
Score: 0.030
-
Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon SR, Venugopal P, Lundberg AS, Powell B. Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia. J Clin Oncol. 2015 Apr 10; 33(11):1252-7.
Score: 0.018